Iodixanol Versus Lopromide At Coronary Ct Angiography: Lumen Opacification And Effect On Heart Rhythm-The Randomized Isocor Trial

Purpose: To show that equal coronary lumen opacification can be achieved with iso- and low-osmolar contrast media when it is injected at the same iodine delivery rate with contemporary cardiac computed tomographic (CT) protocols and to investigate the cardiovascular effect of iso-osmolar contrast media and the image quality achieved.Materials and Methods: Institutional review board approval and written informed consent were obtained for the Effect of Iso-osmolar Contrast Medium on Coronary Opacification and Heart Rhythm in Coronary CT Angiography, or IsoCOR, trial. Between November 2015 and August 2016, 306 patients (167 [55%] women) at least 18 years old (weight range, 50-125 kg), were prospectively randomized to receive iso-osmolar iodixanol 270 or low-osmolar iopromide 300 contrast media. All coronary segments were assessed for intraluminal opacification and image quality and were compared by using the Student t test. Heart rate, arrhythmia, patient discomfort, and adverse events also were monitored.Results: Mean measured coronary attenuation values +/- standard deviation were comparable between the iodixanol 270 and iopromide 300 contrast media groups (469 HU +/- 167 vs 447 HU +/- 166, respectively [P =.241]; 95% confidence interval:-15.1, 60.0), including those from subanalyses. Adjusted for the lower iodine concentration, the mean iodixanol 270 bolus was larger compared with that of iopromide 300 (76.8 mL +/- 11.6 vs 69.7 mL +/- 10.8, respectively; P <.001). The higher injection rate was associated with higher pressure (777 kPa +/- 308 vs 630 kPa +/- 252, respectively; P <.001). Although in the iodixanol 270 group patients experienced less heat discomfort (72% vs 86%, respectively; P <.001), no differences in heart rate or rhythm were observed.Conclusion: If injected at comparable iodine delivery rates, the iso-osmolar contrast medium iodixanol 270 is not inferior to low-osmolar contrast medium iopromide 300 for assessment of coronary opacification. Iodixanol 270 was associated with less heat discomfort, but did not affect heart rate differently compared with iopromide 300. (C) RSNA, 2017